• 1997: Jinhua Lixin Pharmaceutical and Chemical Co., Ltd. was founded
• 2002: Establishment of Zhejiang Nieskang Pharmaceutical Co., Ltd. (Dongxi Factory)
• 2002: Acquisition of Jiangxi Liming Pharmaceutical Factory and Establishment of Jiangxi Lixin Pharmaceutical Co., Ltd.
• 2002: Establishment of Zhejiang Neiskang Pharmaceutical Co., Ltd. (Linjiang Factory)
• December 2009: Successful mergers and acquisitions by Bioveda and NEA
• March 2010: Clarithromycin was certified by PMDA in Japan
• April 2011: Ciprofibrate through COFEPRIS, Mexico
• May 2011: Glimepiride was certified by the Provincial Center for Pharmaceutical and Economic Development in Ciprofibrate.
• April 2012: Azithromycin, Clarithromycin, Roxithromycin and Benzylhydrazine Hydrochloride passed the GMP postponement certification of Jinhua Pharmaceutical Administration.
• June 2013: Azithromycin was certified by PMDA in Japan
• October 2013: Fenofibrate passed GMP postponement certification of Jinhua Drug Administration
• December 2014: Azithromycin was certified by Brazilian ANVISA
• July 2015: Merger and reorganization by Jinhua Kangbei Biopharmaceutical Co., Ltd.
• March 2016: Clarithromycin and Roxithromycin are certified by SFDA on-site GMP
• July 2016: Clarithromycin was certified by EDQM
• September 2016: Benzylhydrazine hydrochloride and azithromycin passed SFDA GMP certification
• August 2018: Ciprofibrate, glimepiride passed the on-site certification of the Provincial Center for Pharmaceutical and Economic Development
• April 2019:Bensihydrazine hydrochloride has passed MFDS site certification in Korea
• September 2019:Clarithromycin passed the Japanese PMDA site certification
Copyright(C)2019,Zhejiang Nexchem Pharmaceutical Co., Ltd. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle Copyright Notice 浙ICP备11057406号-1
Hotline:
+86-579-82203666